Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopausal Women With Bone Predominant, Hormone Receptor Positive Metastatic Breast Cancer

Clinical trial NCT00811369 · COMPLETED

Trial details

NCT number

NCT00811369

Sponsor

Ontario Clinical Oncology Group (OCOG)

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2009-08-01

Primary completion

2012-10-01

Enrollment

126

View on ClinicalTrials.gov